Erratum.
- Published in:
- Journal of Pharmacy Practice, 1995, v. 8, n. 3, p. 137, doi. 10.1177/089719009500800308
- Publication type:
- Article
Works matching IS 08971900 AND DT 1995 AND VI 8 AND IP 3
Results: 8
1
2
The Impact of Controlled Substance Federal Regulation on the Practice of Pharmacy.
- Published in:
- Journal of Pharmacy Practice, 1995, v. 8, n. 3, p. 130, doi. 10.1177/089719009500800307
- By:
- Publication type:
- Article
3
Drug Product Selection in the 1990s: The Pharmacist's Potential Liability in Providing Cognitive Services.
- Published in:
- Journal of Pharmacy Practice, 1995, v. 8, n. 3, p. 121, doi. 10.1177/089719009500800306
- By:
- Publication type:
- Article
4
A Practical Guide to Drug Product Selection: Getting to Know the Food and Drug Administration's (FDA's) Approved Drug Products List (Orange Book) With Therapeutic Equivalence Evaluations.
- Published in:
- Journal of Pharmacy Practice, 1995, v. 8, n. 3, p. 115, doi. 10.1177/089719009500800305
- By:
- Publication type:
- Article
5
Compounding Versus Manufacturing in Pharmacy Practice: A Regulatory Challenge.
- Published in:
- Journal of Pharmacy Practice, 1995, v. 8, n. 3, p. 103, doi. 10.1177/089719009500800304
- By:
- Publication type:
- Article
6
Working Conditions on Public Safety.
- Published in:
- Journal of Pharmacy Practice, 1995, v. 8, n. 3, p. 99, doi. 10.1177/089719009500800303
- Publication type:
- Article
7
The Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy.
- Published in:
- Journal of Pharmacy Practice, 1995, v. 8, n. 3, p. 92, doi. 10.1177/089719009500800302
- Publication type:
- Article
8
Compounding, Generic Drugs, Workload Issues, and Controlled Substances.
- Published in:
- Journal of Pharmacy Practice, 1995, v. 8, n. 3, p. 89, doi. 10.1177/089719009500800301
- By:
- Publication type:
- Article